E-LIB Suche - Ergebnisse für: Rana, Khurram

1

Clinical Outcomes for Patients With Monomicrobial vs Polymi..:

McLeod, Sarah M ; Miller, Alita A ; Rana, Khurram...
Open Forum Infectious Diseases. 11 (2024) 4 - p. , 2024

Link: https://doi.org/10.1093/..

2

85. Efficacy of Sulbactam-Durlobactam (SUL-DUR) Compared to..:

Miller, Alita ; McLeod, Sarah ; Shapiro, Adam B..
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

3

675. Sulbactam-durlobactam (SUL-DUR) versus colistin therap..:

Lewis, Drew ; Rana, Khurram ; Poirier, Gabrielle.
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

4

734. Efficacy of sulbactam-durlobactam (SUL-DUR) versus col..:

Miller, Alita ; McLeod, Sarah ; Shapiro, Adam B...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

5

732. Microbiologic and clinical outcome concordance in the ..:

Altarac, David ; Miller, Alita ; McLeod, Sarah...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

6

225. Efficacy and safety of sulbactam-durlobactam are consi..:

Miller, Alita ; Shapiro, Adam B ; McLeod, Sarah...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

7

1490. Serious Infections Caused by Carbapenem Susceptible a..:

Rana, Khurram ; Wunderink, Richard G ; Tsuei, Betty J...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S747-S747 , 2020

Link: https://doi.org/10.1093/..

8

On‐treatment HCV RNA as a predictor of sustained virologica..:

Kowdley, Kris V. ; Nelson, David R. ; Lalezari, Jacob P....
Liver International. 36 (2016) 11 - p. 1611-1618 , 2016

Link: https://doi.org/10.1111/..

9

A Randomized Study of Peginterferon Lambda-1a Compared to P..:

Flisiak, Robert ; Shiffman, Mitchell ; Arenas, Juan...
PLOS ONE. 11 (2016) 10 - p. e0164563 , 2016

Link: https://doi.org/10.1371/..

10

Su1418 All-Oral Treatment With Daclatasvir Plus Sofosbuvir ..:

Kowdley, Kris V. ; Angus, Peter ; Bernstein, David...
Gastroenterology. 150 (2016) 4 - p. S1094 , 2016

Link: https://doi.org/10.1016/..

11

Tu1013 On-Treatment HCV RNA As a Predictor of Sustained Vir..:

Kowdley, Kris ; Nelson, David ; Lalezari, Jacob...
Gastroenterology. 148 (2015) 4 - p. S-1084 , 2015

Link: https://doi.org/10.1016/..

12

1016 All-Oral 12-Week Combination Treatment With Daclatasvi..:

Nelson, David ; Bernstein, David ; Freilich, Bradley...
Gastroenterology. 148 (2015) 4 - p. S-1003 , 2015

Link: https://doi.org/10.1016/..

13

All‐oral 12‐week treatment with daclatasvir plus sofosbuvir..:

Nelson, David R. ; Cooper, James N. ; Lalezari, Jacob P....
Hepatology. 61 (2015) 4 - p. 1127-1135 , 2015

Link: https://doi.org/10.1002/..

14

820Triple Combination Treatment With Peginterferon Lambda-1..:

Brunetto, Maurizia ; Rana, Khurram ; Taliani, Gloria...
Open Forum Infectious Diseases. 1 (2014) suppl_1 - p. S233-S234 , 2014

Link: https://doi.org/10.1093/..

15

The Safety and Efficacy of Granulocyte‐Macrophage Colony‐St..:

Skowron, Gail ; Stein, Daniel ; Drusano, George...
The Journal of Infectious Diseases. 180 (1999) 4 - p. 1064-1071 , 1999

Link: https://doi.org/10.1086/..